1. Chromosome 17
   Jayasree Debnath et al, 2023, Cancer Genes: Volume 2 CrossRef
2. Development of conformational antibodies targeting Cripto-1 with neutralizing effects in vitro
   Giuseppina Focà et al, 2019, Biochimie CrossRef
3. Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective
   LOKMAN VARISLI et al, 2022, Oncology Research CrossRef
4. KRAS mutation and abnormal expression of Cripto‐1 as two potential candidate biomarkers for detection of colorectal cancer development
   Somayeh Igder et al, 2020, Journal of Cellular Biochemistry CrossRef
5. WNT7A Promotes EGF-Induced Migration of Oral Squamous Cell Carcinoma Cells by Activating β-Catenin/MMP9-Mediated Signaling
   Hui Xie et al, 2020, Frontiers in Pharmacology CrossRef
6. Wnt/β-catenin signal transduction pathway in prostate cancer and associated drug resistance
   Chunyang Wang et al, 2021, Discover Oncology CrossRef
7. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway
   Regina Cheuk-Lam Lo et al, 2018, Cell Death & Differentiation CrossRef
8. Cripto-1 localizes to dynamic and shed filopodia associated with cellular migration in glioblastoma cells
   Johann Mar Gudbergsson et al, 2019, European Journal of Cell Biology CrossRef
9. Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
   David W. Freeman et al, 2021, International Journal of Molecular Sciences CrossRef
10. Teratocarcinoma-derived growth factor-1 (Cripto-1) is overexpressed in epithelial odontogenic lesions displaying more aggressive behaviour
    Leorik Pereira da Silva et al, 2020, Oral and Maxillofacial Surgery CrossRef
11. Cripto-1 is overexpressed in carcinoma ex pleomorphic adenoma of salivary gland
    Leorik Pereira Silva et al, 2018, European Archives of Oto-Rhino-Laryngology CrossRef
12. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy
    Elnaz Pashaei et al, 2017, PLOS ONE CrossRef
13. Zebrafish Microenvironment Elevates EMT and CSC-Like Phenotype of Engrafted Prostate Cancer Cells
    Lanpeng Chen et al, 2020, Cells CrossRef
14. Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells
    Hilal Arnouk et al, 2021, International Journal of Molecular Sciences CrossRef
15. Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers
    Annamaria Sandomenico et al, 2019, Current Medicinal Chemistry CrossRef
16. Knockdown of Cripto-1 inhibits the proliferation, migration, invasion, and angiogenesis in prostate carcinoma cells
    Ding Wu et al, 2017, Journal of Biosciences CrossRef
17. The effects of aging on molecular modulators of human embryo implantation
    Panagiotis Ntostis et al, 2021, iScience CrossRef
18. Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
    Chunxiao Hu et al, 2021, Frontiers in Oncology CrossRef
19. An evaluation of different Cripto‐1 antibodies and their variable results
    Johann Mar Gudbergsson et al, 2020, Journal of Cellular Biochemistry CrossRef
20. Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122
    Rui Su et al, 2017, Molecular Cancer CrossRef
21. Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions
    Eduardo de Paula Nascente et al, 2022, Cancers CrossRef